Alexander Zehnder

Chief Executive Officer

Dr. Alexander Zehnder joined CureVac as CEO in April 2023. He has held roles of increasing complexity and responsibility in the pharmaceutical industry for more than 20 years, across multiple business units and functional areas in Europe, the United States and Japan. Dr. Zehnder has a track record in building pipelines, developing strategies, shaping organizations, and delivering results.

Prior to CureVac, he was Global Head of Oncology at Sanofi and held country leadership positions at both headquarter and country level. Dr. Zehnder was also a member of the Oncology leadership team at Roche/Genentech, serving as Vice President, Global Product Strategy and Global Franchise Head Avastin, the company’s blockbuster oncology drug.

He earned his degree as a Medical Doctor from the University of Bern, Switzerland, and completed an MBA at IMD Business School in Lausanne, Switzerland.

Back to Executive Board